Incidence and risk of severe neutropenia in advanced cancer patients treated with cetuximab: a meta-analysis
about
A phase I study of concurrent individualized, isotoxic accelerated radiotherapy and cisplatin-vinorelbine-cetuximab in patients with stage III non-small-cell lung cancer.Infectious complications in head and neck cancer patients treated with cetuximab: propensity score and instrumental variable analysisTreatment related severe and fatal adverse events with cetuximab in colorectal cancer patients: a meta-analysis.
P2860
Incidence and risk of severe neutropenia in advanced cancer patients treated with cetuximab: a meta-analysis
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Incidence and risk of severe n ...... ith cetuximab: a meta-analysis
@ast
Incidence and risk of severe n ...... ith cetuximab: a meta-analysis
@en
type
label
Incidence and risk of severe n ...... ith cetuximab: a meta-analysis
@ast
Incidence and risk of severe n ...... ith cetuximab: a meta-analysis
@en
prefLabel
Incidence and risk of severe n ...... ith cetuximab: a meta-analysis
@ast
Incidence and risk of severe n ...... ith cetuximab: a meta-analysis
@en
P2093
P2860
P1433
P1476
Incidence and risk of severe n ...... ith cetuximab: a meta-analysis
@en
P2093
P2860
P304
P356
10.2165/11598190-000000000-00000
P577
2011-12-01T00:00:00Z